Brief: Redhill Announces First Patient Enrolled In US Government-Supported COVID-19 Study
April 24 (Reuters) - Redhill Biopharma Ltd 2RH0y.F :
* REDHILL ANNOUNCES FIRST PATIENT ENROLLED IN U.S.
GOVERNMENT-SUPPORTED COVID-19 STUDY
Source text for Eikon: ID:nPn7g7HX6a
Further company coverage: 2RH0y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Heidelberg Pharma AG
See all newsBrief: Heidelberg Pharma Says Co. And Healthcare Royalty Announce Amendment To Existing Royalty Agreement
Brief: Redhill Biopharma Secures Allowance Of Key Chinese Patent Application For Proprietary COVID-19 Treatment, RHB-107
Brief: Heidelberg Pharma Amends Royalty Financing With Healthcare Royalty
Brief: Heidelberg Pharma Expects FY EBIT Between EUR -19 Mln And EUR -22 Mln
Brief: Heidelberg Pharma AG: Announces Updated Guidance